Preclinical efficacy testing is a key step in drug development.
To better evaluate the efficacy of new therapies, our team at Voxcan strives to develop and characterize animal models that most reliably reflect human disease, with appropriate study design (control group/reference group/test groups).
Our choice of high-technology techniques such as non-invasive imaging enables to generate optimal quantification of your preferred efficacy endpoints (tumor growth, infection progression…), ensuring accurate measurements and improving the translatability of your preclinical results to human studies.
